DBV Technologies DBVT Expenses by Nature — Share-based payments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DBV Technologies in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about DBV Technologies's expenses by nature — share-based payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is DBV Technologies's expenses by nature — share-based payments?
- DBV Technologies (DBVT) reported expenses by nature — share-based payments of $2.3M in Q1 2026.
- How has DBV Technologies's expenses by nature — share-based payments changed year-over-year?
- DBV Technologies's expenses by nature — share-based payments increased by 35.3% year-over-year, from $1.7M to $2.3M.
- What is the long-term trend for DBV Technologies's expenses by nature — share-based payments?
- Over 3 years (2022 to 2025), DBV Technologies's expenses by nature — share-based payments has grown at a 2.3% compound annual growth rate (CAGR), from $5.03M to $5.39M.
- What does expenses by nature — share-based payments mean?
- Represents the non-cash expense recognized for equity-based compensation, such as stock options or restricted stock units granted to employees and directors. This metric aligns the interests of the workforce with shareholders and is a critical component of total compensation in high-growth biopharmaceutical firms. It highlights the cost of talent retention through equity incentives.